The first research published about the cannabinoids in ‘Indian Hemp” was in 1843 by Dr. W.B. O’Shaughnessy. The CBN cannabinoid, cannabinol, was first identified in 1899 and it wasn’t until the 1940’s when researchers were able to identify other cannabinoids including: THC, CBD and CBN.
Between 1940 and the implementation of the Single Convention on Drug Control in 1961, extensive research uncovered medicinal properties associated with these preliminary cannabinoids. The first patent filed regarding a compound of cannabis was in 1942 when cannabidiol (CBD) was isolated.
After the 1961 Convention was concluded, Raphael Mechoulam and his research partners at the Hebrew University of Jerusalem isolated and established the structure of THC and synthesized it in 1971. This discovery lead to further research and identification of a number of other cannabinoids that possessed fascinating medicinal properties.
Despite the fact that cannabis oil was included as medicine in the British and US Pharmacopoeia and used since the beginning of time as medicine in the east, it posed a threat to the pharmaceutical industry’s plan of taking over medicine. As a result, it became subject to criminal controls following the adoption of the Single Convention on Drug Control, and was then deemed a dangerous Schedule I drug – with a high potential for abuse; no accepted medical use and no known safety standard for its use. Despite these outlandish claims, the government continued to file patent applications on their research, without any competition.
The UN established itself as the international competent organization to handle the control of narcotic drugs through its numerous agencies, committees, commissions, and treaty resolutions it set up.
The UNITED NATION – is NOT in a position to dictate on Cannabis
The UN, in its quest to vilify this plant, adopted an arbitrary method of identifying and classifying cannabis as to drug or fibre (industrial) type based on a ratio of total THC + CBN : CBD. If the ratio is less than one, according to the UN, it is deemed to be hemp; conversely, if the ratio is greater than 1, it is a drug of the most dangerous type. The problem with this method of identifying cannabis is two-fold. First, cannabinoids are only formed in the trichomes of female flowers and therefore, the method of adding THC to CBN as a ratio of CBD – is inherently incorrect.
Hemp is grown for its seeds or stalk, NOT for female unfertilized flowers. In other words, there is very little medicinal cannabinoids found in industrial hemp and using ration of THC to CBD will be a false positive fibre type if the ratio is < 1.
Although the hemp plant does not produce a significant quantity of medicinal cannabinoids, industrial hemp seeds do contain a plethora of health benefits and has its own unique medicinal properties, such as cannabisin B.
The United Nation’s Error Number Two
The other problem with the UN’s definitive method for analyzing cannabis, is with their recommended method of chromatography.
The United Nations recommends using gas chromatography as the method of separating cannabinoids in a sample. However, since the adoption of the
Single Convention on Drug Control in 1961, the UN continues to only focus on the aforementioned three cannabinoids – THC, CBN and CBD. Since the UN wrote their Recommendation for Identifying and Classifying Cannabis, it was subsequently discovered that a 5-type MS GC column is unable to fully separate cannabichromene (CBC) from cannabidiol (CBD). This has resulted in mistaking CBC for CBD.
Since the United Nations established itself as the international competent organization to handle the control of cannabis, it has failed as a competent organization. The Single Convention was organized to control the illicit drug trade. However, prescription medicine continues to harm children, causing unbearable addiction, and violent behavior along with other psychiatric disorders such as suicide .